Pacira BioSciences Inc.
PCRX | NASDAQ
$24.84
+$0.73 (+3.03%)
Sep 22, 2026, 2:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 158.55M | 276.77M | 153.3M | 104.14M | 585.58M | 99.96M |
Short-Term Investments | 79.88M | 207.84M | 125.28M | 184.51M | 70.83M | 421.71M |
Long-Term Investments | n/a | 29.45M | 2.41M | 37.21M | n/a | 95.46M |
Other Long-Term Assets | 22.31M | 6.2M | 36.05M | 27.17M | 21.99M | 14.02M |
Receivables | 124.07M | 113.3M | 105.56M | 98.4M | 96.32M | 53.05M |
Inventory | 152.86M | 125.28M | 104.35M | 96.06M | 98.55M | 64.65M |
Other Current Assets | 32.62M | 21.93M | 21.5M | 15.22M | 100K | n/a |
Total Current Assets | 547.97M | 745.13M | 509.99M | 498.33M | 866.05M | 651.62M |
Property-Plant & Equipment | 182.47M | 216.39M | 234.95M | 254.39M | 264.81M | 211.18M |
Goodwill & Intangibles | 388.31M | 425.97M | 646.5M | 703.79M | 769.14M | 196.07M |
Total Long-Term Assets | 716.94M | 808.39M | 1.06B | 1.18B | 1.21B | 622.89M |
Total Assets | 1.26B | 1.55B | 1.57B | 1.68B | 2.08B | 1.27B |
Account Payables | 15.15M | 19.13M | 15.7M | 15.22M | 10.54M | 10.43M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 9.84M | 201.78M | 8.64M | 33.65M | 374.7M | 149.65M |
Other Current Liabilities | 95.6M | 28.81M | 42.56M | 26.2M | 45.49M | 36.94M |
Total Current Liabilities | 120.59M | 309.92M | 97.38M | 147.77M | 521.12M | 253.33M |
Long-Term Debt | 408.37M | 383.55M | 513.8M | 655.82M | 674.53M | 313.03M |
Other Long-Term Liabilities | 2.46M | 37.06M | 38.27M | 37.79M | 67.45M | 17.44M |
Total Long-Term Liabilities | 451.22M | 465.25M | 606.87M | 758.42M | 823.83M | 401.5M |
Total Liabilities | 571.81M | 775.17M | 704.26M | 906.19M | 1.34B | 654.83M |
Total Debt | 454.38M | 638.85M | 586.04M | 763.39M | 1.13B | 541.13M |
Book Value | 693.11M | 778.35M | 870.13M | 775.01M | 730.41M | 619.69M |
Book Value Per Share | 15.39 | 16.83 | 16.74 | 16.65 | 16.01 | 14.19 |
Common Stock | 48K | 47K | 46K | 46K | 45K | 44K |
Retained Earnings | -199.32M | -206.36M | -106.8M | -148.75M | -211.9M | -253.88M |
Comprehensive Income | 4.33M | 343K | 247K | -380K | 167K | 318K |
Shareholders Equity | 693.11M | 778.35M | 870.13M | 775.01M | 730.41M | 619.69M |
Total Investments | 79.88M | 237.29M | 127.69M | 221.72M | 70.83M | 517.16M |
Add to Watchlist
Select watchlists to add or remove PCRX